New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test...
- Women's Health
- 06/12/2022
The Breast Cancer Index Test Is the First Biomarker to Predict Treatment Benefit in the SOFT Trial Hologic , Inc. and its subsidiary, Biotheranostics, Inc., announced new study data showing...
READ MORE